Cosmetic products and women's health;Kozmetik ürünler ve kadın sağlığı

TAF Preventive Medicine Bulletin

Volumn 13, Issue 5, 2014, Pages 413-420

  Kocaöz, Semra ^a   Eroğlu, Kafiye ^b  

^a NIGDE UNIVERSITY   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

Cosmetic; Health problems; Personal care products; Women

Indexed keywords

COSMETIC;

AWARENESS; FEMALE; HUMAN; KNOWLEDGE; REVIEW; SOCIETY; WOMEN'S HEALTH;

EID: 84916602259     PISSN: 1303734X     EISSN: None     Source Type: Journal    
DOI: 10.5455/pmb.1-1369226059     Document Type: Review

References (53)

1. Demirezer LÖ. Fitokozmesötikler. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2008; 28 (Suppl): S178-S181.
2. Kandi B, Kaya H, Özünal ZG. Kozmetik emilim sistemleri. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 1-6.
3. Karaduman A. Kozmetikler ve Kadın. Eds.: Akın A. In: Toplumsal cinsiyet, sağlık ve kadın. Ankara: Hacettepe Üniversitesi Yayınları; 2003. p. 175-189.
4. Yazan Y. Kozmetik Bilimi. 2nd edition. Ankara: Nobel Kitabevleri; 2010.
5. Batı U. Reklamcılıkta retorik bir unsur olarak kadın bedeni temsilleri. Kültür ve İletişim. 2010; 13(1):103-133.
6. Papatya N, Karaca Y. Reklamlardaki kadın imgesi: ulusal televizyon reklamlarına ilişkin bir değerlendirme. Süleyman Demirel Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi. 2011; 16(3): 479-500.
7. Gökdemir G, Arı S, Köşlü A. Türk toplumunda deri bakımı ile ilgili bilgi seviyesinin değerlendirilmesi. Türkderm. 2008; 42(2): 60-63.
8. Choi CM, Berson DS. Cosmeceuticals. Seminars in Cutaneous Medicine and Surgery. 2006; 25(3): 163-168.
9. Özer Ö. Bilimden Pratiğe kozmesötikler. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2008; 28 (Suppl): 175-177.
10. Borlu M. Kozmetiklerle oluşan kontakt alerji paternleri. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 87-93.
11. Millikan LE. Cosmetology, cosmetics, cosmeceuticals: definations and regulations. Clinics Dermatology. 2001;19: 371-374.
12. Çomoğlu T. Kozmetikler. Marmara Pharmaceutical Journal. 2012; 16: 1-8.
13. Brody HJ. Relevance of cosmeceuticals to the dermatologic surgeon. Dermatologic Surgery. 2005; 31: 796-798.
14. Karıncaoğlu Y. Kozmesötikler: mitler ve yanlış bilinenler. Türkiye Klinikleri Journal of Cosmetic Dermatology Special Topics. 2012; 5(1): 94-98.
15. Russ K. Health effects of personal care products. a review of the evidence. Nursing for Women's Health. 2009; 13(5): 392-401.
16. Castanedo-Tardan MP, Zug KA. Patterns of cosmetic allergy. Dermatologic Clinics. 2009; 27(3): 265-280, vi.
17. Scheman A. Adverse reactions to cosmetic ingredients. Dermatologic Clinics. 2000; 18(4): 685-698.
18. Nohynek GJ, Antignac E, Re T, Toutain H. Safety assesment of personal care products/cosmetics and their ingredients. Toxicology and Applied Pharmacology. 2010; 243: 239-259.
19. Kozmetik Yönetmeliği. T.C. Resmi Gazete, 25823, 23 Mayıs 2005.
20. Draelos ZD. Are cosmetics safe? Journal of Cosmetic Dematology. 2012; 11: 249-250.
21. Food and Drug Administration (FDA). 2002. Is it a cosmetic, a drug, or both? (or is it soap?).http://www.fda.gov/cosmetics/guidancecom plianceregulatoryinformation/ucm074201.htm [Acces date: 31.01.2013].
22. Newburger AE. Cosmeceuticals: myths and misconceptions. Clinics in Dermatology. 2009; 27(5): 446-452.
23. Food and Drug Administration (FDA). 2003. Color additives: FDA's regulatory process and historical perspectives. Barrows JN, Lipman AL, Bailey CJ. http://www.fda.gov/ForIndustry/ColorAdditives/Reg ulatoryProcessHistoricalPerspectives/default.htm [Acces date: 31.01.2013].
24. Food and Drug Administration (FDA). 2005. FDA authority over cosmetics. http://www.fda.gov/ Cosmetics/GuidanceComplianceRegulatoryInform ation/ucm074162.htm [Acces date: 31.01.2013].
25. Bakar C, Baba A. Metaller ve insan sağlığı: yirminci yüzyıldan bugüne ve geleceğe miras kalan çevre sağlığı sorunu. I. Tıbbi Jeoloji Çalıştayı, Ürgüp/Nevşehir: 2009. p. 162-185.
26. Durmaz E, Özmert EN. Fitalatlar ve çocuk sağlığı. Çocuk Sağlığı ve Hastalıkları Dergisi. 2010; 53: 305-317.
27. Koniecki D, Wang R, Moody RP, Zhu J. Phtalate in cosmetic and personal care products: concentrations and dermal exposure. Environmental Research. 2011; 111: 329-336.
28. Koo HJ, Lee BM. Estimated exposure to phthalates in cosmetics and risk assessment. Journal of Toxicology and Environmental Health. 2004; 67(23-24): 1901-1914.
29. Pehlivan M, Pehlivan E, Özler MA. İnsan sağlığı üzerine civa ve civa bileşiklerinin etkisi. Çevre Dergisi. 1993; 8: 33-35.
30. Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Critical Reviews in Toxicology. 2000; 30(2): 135-196.
31. Liu T, Wu D. High-performance liquid chromatographic determination of triclosan and triclocarban in cosmetic products. International Journal of Cosmetics Science. 2012; 34: 489-494.
32. Glaser A. The Ubiquitous triclosan. A common antibacterial agent exposed. Pesticides and You Beyond Pesticides/National Coalition Against the Misuse of Pesticides. 2004; 24(3): 12-17.
33. Ballesta Claver J, Valencia MC, Capitán-Vallvey LF. Analysis of parabens in cosmetics by low pressure liquid chromatography with monolithic column and chemiluminescent detection. Talanta. 2009; 79: 499-506.
34. The Campaign for Safe Cosmetics. Parabens. http://safecosmetics.org/article.php?id=291 [Acces date: 10.05.2013].
35. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MG, Pore GS. Concentration of parabens in human breast tumors. Journal of Applied Toxicology. 2004; 24(1): 5-13.
36. Epstein H. Cosmetics preservation. Clinics in Dermotology. 2006; 24: 551-552.
37. Çetinkaya S. Endokrin bozucular ve ergenlik üzerine etkileri. Dicle Tıp Dergisi. 2009; 36(1): 59-66.
38. European Comission. 2001. Opinion concerning Dialkyl- and Dialkanolamines and their salts in cosmetic products adopted by the SCCNFP during the 17th plenary meeting of 12 June. http://ec.europa.eu/health/scientific_committees/co nsumer_safety/opinions/sccnfp_opinions_97_04/s ccp_out144_en.htm [Acces date: 22.02.2013].
39. Schothorst RC. Somer HHJ. Determination of Nnitrosodiethanolamine in cosmetic products by LC-MS-MS. Analytical and Bioanalytical Chemistry. 2005; 381:681-685.
40. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environmental Health Perspectives. 2001; 109: 239-244.
41. Tekbaş ÖF. Kimyasallar ve üreme sağlığı. TSK Koruyucu Hekimlik Bülteni. 2006; 5(1): 50-59.
42. Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. Blood lead concentration and delayed puberty in girls. The New England Journal of Medicine. 2003; 348: 1527-1536.
43. The Campaign for Safe Cosmetics. Hundreds of lipsticks contaminated with lead, reports new FDA study. http://safecosmetics.org/article.php?id=952 [Acces date: 22.02.2013].
44. Food and Drug Administration (FDA). Lipstick and Lead: Questions and Answers. http://www.fda.gov/Cosmetics/ProductandIngredie ntSafety/ProductInformation/ucm137224.htm#exp analyses [Acces date: 22.02.2013].
45. Darbre PD. Enviromental oestrogens, cosmetics and breast cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 2006; 20(1): 121-143.
46. The Campaign for Safe Cosmetics. 1,4 Dioxane. http://safecosmetics.org/article.php?id=288 [Acces date: 10.05.2013].
47. Karadağ ÖK. Solvent nedenli sağlık risklerinin yönetimi. Türk Tabipleri Birliği Mesleki Sağlık ve Güvenlik Dergisi. 2005;21-27.
48. Ünsaldı E, Çiftçi K. Formaldehit, kullanım alanları, risk grubu, zararlı etkileri ve koruyucu önlemler. YYÜ Veteriner Fakültesi Dergisi. 2010;21(7): 71-75.
49. Kireche M, Gimenez-Arnau E, Lepoittevin J-P. Preservatives in cosmetics: reactivity of allergenic formaldehyde-releasers towards amino acids through breakdown products other than formaldehyde. Contact Dermatitis. 2010; 63: 192-202.
50. The Campaign for Safe Cosmetics. Formaldehyde and formaldehyde-releasing preservatives. http://safecosmetics.org/article.php?id=599. [Acces date: 11.05.2013].
51. The Campaign for Safe Cosmetics. Hydroquinone. http://safecosmetics.org/article.php?id=288 [Acces date: 11.05.2013].
52. Löffler H, Freyschmidt-Paul P, Effendy I, Maibach H. Pitfalls of irritant patch testing using different test chamber sizes. American Journal of Contact Dermatitis. 2001; 12(1): 28-32.
53. Petrini C, Vecchia P. Statements and definitions of the precautionary principle. IEEE Technology and Society Magazine. Winter 2002/2003; 4-7.